Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00735191

Ligand	Ligand name	Chain	PDB	Tanimoto
GNT	(-)-GALANTHAMINE	A	1DX6	0.72
GNT	(-)-GALANTHAMINE	A	1QTI	0.72
GNT	(-)-GALANTHAMINE	A,B,C,D,E	2PH9	0.72
GNT	(-)-GALANTHAMINE	A,B	1W76	0.72
GNT	(-)-GALANTHAMINE	A	1W6R	0.72
442	2-[3,5-DIBROMO-4-(4-HYDROXY-3-{HYDROXY[(2-PHENYLETHYL)AMINO]METHYL}PHENOXY)PHENYL]ETHANE-1,1-DIOL	A	1R6G	0.81
SFX	(3S)-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine	A	3GWW	0.72
P12	4-[AMINO(IMINO)METHYL]-1-[2-(3-AMMONIOPROPOXY)-5-METHOXYBENZYL]PIPERAZIN-1-IUM	B	1UUI	0.71
P14	N-[2-(2-{[(4-{[AMINO(IMINO)METHYL]AMINO}BUTYL)AMINO]METHYL}-4-METHOXYPHENOXY)ETHYL]GUANIDINE	B	1UUD	0.74
DPD		A,B	1QIW	0.8
DPD		A	1QIV	0.8
ANM	ANISOMYCIN	1,2,4,A,B,C,D,E,J,K,L,M,N,O,P,R,S,T,U,V,Z	1K73	0.71
ANM	ANISOMYCIN	0,1,3,9,A,B,C,F,H,J,K,L,M,N,O,Q,R,S,T,U,Y,Z	3CC4	0.71
RFX	(3R)-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine	A	3GWV	0.72
TMS	N-PROPYL-4-[(E)-2-(3,4,5-TRIMETHOXY-PHENYL)-VINYL]-BENZAMIDE	A,B	1X6W	0.71
4SR	(4S)-4-[3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]PYRROLIDIN-2-ONE	A,B	1XN0	0.71
SLX	(13aS)-3,10-dimethoxy-5,8,13,13a-tetrahydro-6H-isoquino[3,2-a]isoquinoline-2,9-diol	A	3FW9	0.71
ROL	ROLIPRAM	A,B,C,D	1OYN	0.71
ROL	ROLIPRAM	A,B	1XMY	0.71
ROL	ROLIPRAM	A,B,C,D	1Q9M	0.71
ROL	ROLIPRAM	A,B	1RO6	0.71
ROL	ROLIPRAM	A,B	1XN0	0.71
ROL	ROLIPRAM	A,B	1TBB	0.71
F1L	N-[1-(5-bromo-2,3-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide	A	2ZJL	0.76
CMZ	(2S)-1-(2,5-dimethylphenoxy)-3-morpholin-4-ylpropan-2-ol	A	2OF0	0.72
MR1	1-(1,3-BENZODIOXOL-5-YL)METHANAMINE	A	2ORQ	0.7
HV8	BENZYL-2-AMINO-PARAMETHOXY-BENZYLSTATINE	C	1A8G	0.72
REN	(S)-reticuline	A	3FWA	0.73
REN	(S)-reticuline	A	3D2D	0.73
TAX	(Z)-2-[4-(1,2)-DIPHENYL-1-BUTENYL)-PHENOXY]-N,N-DIMETHYLETHANAMINIUM	A	1FJ5	0.72
2TN	2-(4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)PHENYL)ETHANAMIDE	A	2OTF	0.71
2TN	2-(4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)PHENYL)ETHANAMIDE	A	2NUV	0.71
2TN	2-(4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)PHENYL)ETHANAMIDE	A	2OUB	0.71
SNP	1-(ISOPROPYLAMINO)-3-(1-NAPHTHYLOXY)-2-PROPANOL	A	1DY4	0.75
LDT	IDD594	A	1US0	0.76
LDT	IDD594	A	3GHU	0.76
LDT	IDD594	A	3GHT	0.76
LDT	IDD594	A	2I17	0.76
LDT	IDD594	A	2QXW	0.76
LDT	IDD594	A	3GHS	0.76
LDT	IDD594	A	3GHR	0.76
LDT	IDD594	A	2PEV	0.76
LDT	IDD594	A	2I16	0.76
LDT	IDD594	A	2PF8	0.76
LDT	IDD594	A	2PFH	0.76
LDT	IDD594	A	2R24	0.76
TXF	(Z)-4-(1-{4-[2-(DIMETHYLAMINO)ETHOXY]PHENYL}-5-HYDROXY-2-PHENYLPENT-1-ENYL)PHENOL	A,B,C,D,E	2EWP	0.7
C61	(2R,4S,5S,7S)-5-AMINO-N-BUTYL-4-HYDROXY-7-[4-METHOXY-3-(3-METHOXYPROPOXY)BENZYL]-2,8-DIMETHYLNONANAMIDE	C,O	2V10	0.71
5RM	(5R)-5-(4-methoxy-3-propoxyphenyl)-5-methyl-1,3-oxazolidin-2-one	A,B	1XM6	0.71
XX6	2-{[(2R)-2-HYDROXY-3-(9-PHENANTHRYLOXY)PROPYL]AMINO}PROPANE-1,3-DIOL	A	2V3I	0.71
XX7	2-{[(2S)-2-HYDROXY-3-(9-PHENANTHRYLOXY)PROPYL]AMINO}PROPANE-1,3-DIOL	A	2V3R	0.71
Y12	4-{(1E)-3-OXO-3-[(2-PHENYLETHYL)AMINO]PROP-1-EN-1-YL}-1,2-PHENYLENE DIACETATE	A	2EW5	0.74